产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
CAS No. |
1044871-04-6 |
|---|---|
中文名称 |
2-[3,5-二甲基-4-(2-吡咯烷-1-基乙氧基)苯基]-5,7-二甲氧基-3H-喹唑啉-4-酮 |
英文名称 |
2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one |
别名 |
RVX297;4(3H)-Quinazolinone, 2-[3,5-dimethyl-4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-5,7-dimethoxy-;2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one;autoimmunity,RVX 297,proinflammatory,Epigenetic Reader Domain,RVX-297,immune,inhibit,mediator,inflammatory,Inhibitor,selectivity,acute,cell,arthritis;2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(1H)-one;2-{3,5-dimethyl-4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-5,7-dimethoxy-1,4-dihydroquinazolin-4-one;2-(3,5-Dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one , RVX-297;RVX-297, 10 mM in DMSO |
标准英文名 |
2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one |
分子式 |
C24H29N3O4 |
分子量 |
423.51 |
精确分子量 |
423.22 |
SMILES |
O=C1NC(C2=CC(C)=C(OCCN3CCCC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4 |
标准SMILES |
CC1C=C(C=C(C)C=1OCCN1CCCC1)C1NC(=O)C2C(=CC(=CC=2N=1)OC)OC |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
PQZDYFRDRHRZGF-UHFFFAOYSA-N |
危险类别(旧) |
H302,H312,H332 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Acute toxicity, dermal (Category 4),Acute toxicity, inhalation (Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|